Islet Autoantibody (IA) Screening Options for the Early Detection of Type 1 Diabetes (T1D)
A comprehensive reference of currently available islet autoantibody (IA) screening options for the early detection of type 1 diabetes (T1D) prior to clinical signs or symptoms. Four screening modalities are covered, including local consumer laboratories, online ordering with clinic delivery, and clinical trials such as TrialNet and the Autoimmunity Screening for Kids (ASK) program, with detail on the specific autoantibodies assessed (GADA, IAA, IA-2A, ZnT8A, ICA), blood draw locations, and sampling methods. Intended to support HCPs in identifying appropriate screening pathways for individual patients and facilitating referrals to available programs. Content is current at time of publication; availability may vary by state.
MAT-US-2605739 v1.0-P Exp Date: 05/26/2028